Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

KPTI Stock Annual Cash Flow. Download in Excel

Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

0.77
 
USD
  
-0.03
  
(-3.54%)
Previous close: 0.7964  Open: 0.773  Bid: 0.7981  Ask: 0.8398
52 week range    
0.62   
   1.95
Mkt Cap: 102 M  Avg Vol (90 Days): 795,423
Peers   
MRK / 
BMY / 
ABT / 
Last updated: Monday 9th December 2024

Stock Rankings

40
MarketXLS Rank
40
Value
30
Technical
50
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

KPTI Cash Flow

Annual
Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
(Increase) Decrease in inventories-346000.0-3 M-1 M-118000.01 M
(Increase) Decrease in other current assets-470000.0500000.0
(Increase) Decrease in other current liabilities-79000.022 M-8 M-9 M-4 M-297000.0
(Increase) Decrease in other working capital-20 M
(Increase) Decrease in payables4 M-2 M945000.0909000.0-1 M-3 M3 M-3 M1 M350000.0
(Increase) Decrease in receivables-8 M-5 M-10 M-5 M20 M
Acquisitions-5 M
AssetImpairmentCharge329000.0
CapitalExpenditureReported3 M1 M70000.062000.02 M206000.0145000.0212000.0118000.0
Cash at beginning of period156 M151 M58 M50 M69 M119 M131 M89 M197 M137 M
Cash at end of period151 M58 M50 M69 M119 M131 M89 M197 M137 M53 M
Cash flow-51 M-94 M-84 M-74 M-159 M-191 M-160 M-107 M-150 M-93 M
CashFlowFromContinuingInvestingActivities-67 M-91 M25 M17 M-108 M78 M-54 M142 M-104 M8 M
ChangeInAccountPayable4 M-2 M945000.0909000.0-1 M-3 M3 M-3 M1 M350000.0
ChangeInAccruedExpense4 M6 M368000.010 M11 M9 M12 M16 M-10 M4 M
ChangeInInterestPayable4 M6 M368000.010 M11 M
ChangeInPayablesAndAccruedExpense9 M3 M1 M11 M10 M5 M16 M13 M-8 M4 M
ChangeInPrepaidAssets1 M158000.0-326000.062000.0-2 M-868000.0-2 M-25 M-6 M7 M
ChangeInWorkingCapital10 M4 M987000.033 M-169000.0-13 M2 M-23 M-19 M32 M
ChangesInAccountReceivables-8 M-5 M-10 M-5 M20 M
Depreciation323000.0634000.0717000.0713000.0700000.01000000.01000000.0789000.0621000.0530000.0
Depreciation unreconciled325000.02 M2 M2 M2 M7 M10 M3 M608000.0-3 M
DepreciationAndAmortization325000.02 M2 M2 M2 M7 M972000.0789000.0621000.0-3 M
Effect of exchange rate changes-8000.0-99000.0-63000.0211000.0-78000.019000.0268000.0-48000.0-488000.0-34000.0
FinancingCashFlow113 M93 M51 M76 M316 M124 M172 M74 M194 M1 M
Free cash flow-54 M-95 M-84 M-74 M-162 M-191 M-160 M-107 M-150 M-93 M
GainLossOnInvestmentSecurities-515000.0-116000.0
GainLossOnSaleOfPPE50000.0
InterestPaidSupplementalData5 M5 M5 M
Issuance of capital stock113 M92 M51 M75 M146 M46 M162 M10 M190 M
IssuanceOfCapitalStock113 M92 M51 M75 M146 M46 M162 M10 M190 M
IssuanceOfDebt167 M
Net cash from financing activities113 M93 M51 M76 M316 M124 M172 M74 M194 M1 M
Net cash from investing activities-67 M-91 M25 M17 M-108 M78 M-54 M142 M-104 M8 M
Net cash from operating activities-51 M-94 M-84 M-74 M-159 M-191 M-160 M-107 M-150 M-93 M
Net change in cash & cash equivalents-5 M-92 M-9 M19 M49 M12 M-42 M108 M-60 M-84 M
Net income from continuing operations-76 M-118 M-110 M-129 M-178 M-200 M-196 M-124 M-165 M-143 M
NetBusinessPurchaseAndSale-5 M
NetCommonStockIssuance113 M92 M51 M75 M146 M46 M162 M10 M190 M
NetInvestmentPropertiesPurchaseAndSale-64 M-89 M25 M17 M-105 M79 M-54 M148 M-104 M8 M
NetInvestmentPurchaseAndSale-64 M-89 M25 M17 M-105 M79 M-54 M148 M-104 M8 M
NetIssuancePaymentsOfDebt167 M
NetPPEPurchaseAndSale-3 M-1 M-70000.0-62000.0-2 M-206000.0-145000.0-212000.0-118000.0
Operating (gains) losses50000.0-515000.0-116000.0
Other financing charges net-39000.0167 M74 M60 M
Other investing changes net-400000.0-82000.0
Other non-cash items14 M18 M22 M20 M17 M15 M24 M37 M34 M21 M
ProceedsFromStockOptionExercised284000.0616000.0630000.0858000.04 M5 M10 M4 M4 M1 M
Purchase of Float term investments-64 M-305 M-135 M-98 M-243 M-178 M-275 M-45 M-226 M-159 M
Purchase of property plant & equipment-3 M-1 M-70000.0-62000.0-2 M-206000.0-145000.0-212000.0-118000.0
PurchaseOfInvestment-64 M-305 M-135 M-98 M-243 M-178 M-275 M-45 M-226 M-159 M
PurchaseOfPPE-3 M-1 M-70000.0-62000.0-2 M-206000.0-145000.0-212000.0-118000.0
Revenue per share2000.02 M1 M1 M1 M6 M9 M2 M-13000.0-3 M
Sale of short term investments216 M159 M116 M138 M257 M221 M193 M122 M167 M
SaleOfInvestment216 M159 M116 M138 M257 M221 M193 M122 M167 M
StockBasedCompensation14 M17 M22 M20 M17 M15 M24 M30 M35 M22 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University